Lakefront Biotherapeutics (LKFT) Assets Growth (3y) (2016 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Assets Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -7.40% |
| Dec 31, 2025 | -6.37% |
| Mar 31, 2025 | -9.59% |
| Dec 31, 2024 | -9.39% |
| Dec 31, 2023 | -11.73% |
| Mar 31, 2023 | -9.08% |
| Dec 31, 2022 | -10.41% |
| Mar 31, 2022 | 53.22% |
| Dec 31, 2021 | 53.49% |
| Jun 30, 2021 | 65.71% |
| Dec 31, 2020 | 65.11% |
| Jun 30, 2020 | 62.41% |
| Mar 31, 2020 | 79.54% |
| Dec 31, 2019 | 79.08% |
| Jun 30, 2019 | 8.18% |
| Dec 31, 2018 | 50.18% |
| Dec 31, 2017 | 2,159.83% |
| Dec 31, 2016 | 44.07% |